Lenacapavir

CHEMBL4594438 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

968.3 g/mol

LogP

6.4

Phase

4

A first-in-class HIV-1 capsid inhibitor used to treat multidrug-resistant HIV infection in combination with other antiretrovirals. It works at multiple stages of the viral life cycle by disrupting the protein shell that protects HIV's genetic material.

الوزن الجزيئي

968,3000 g/mol

LogP

6,40

TPSA

175,00 Å²

قاعدة ليبينسكي للخمسة

راسب

المجالات العلاجية

HIV/AIDS

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)(C#Cc1ccc(-c2ccc(Cl)c3c(NS(C)(=O)=O)nn(CC(F)(F)F)c23)c([C@H](Cc2cc(F)cc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2C(F)(F)[C@@H]2C[C@H]32)n1)S(C)(=O)=O

InChI

InChI=1S/C39H32ClF10N7O5S2/c1-36(2,63(3,59)60)10-9-21-5-6-22(23-7-8-26(40)30-32(23)57(17-37(43,44)45)54-35(30)55-64(4,61)62)31(51-21)27(13-18-11-19(41)14-20(42)12-18)52-28(58)16-56-34-29(33(53-56)39(48,49)50)24-15-25(24)38(34,46)47/h5-8,11-12,14,24-25,27H,13,15-17H2,1-4H3,(H,52,58)(H,54,55)/t24-,25+,27-/m0/s1

Molecular Formula

C39H32ClF10N7O5S2

HBD / HBA

2 / 19

الروابط القابلة للدوران

13

الذرات الثقيلة

64

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

A first-in-class HIV-1 capsid inhibitor used to treat multidrug-resistant HIV infection in combination with other antiretrovirals. It works at multiple stages of the viral life cycle by disrupting the protein shell that protects HIV's genetic material.

Yes, Lenacapavir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594438. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 133082658. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Lenacapavir على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C39H32ClF10N7O5S2
المرادفات: 2

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.